losartan has been researched along with Liver Cirrhosis, Biliary in 2 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Liver Cirrhosis, Biliary: FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow (CHOLESTASIS) in the intrahepatic or extrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC). Primary biliary cholangitis involves the destruction of small intra-hepatic bile ducts and decreased bile secretion. Secondary biliary cholangitis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We studied, in rats with secondary biliary cirrhosis and sham-operated rats, the effect of 0." | 5.33 | Vascular, hemodynamic and renal effects of low-dose losartan in rats with secondary biliary cirrhosis. ( Heller, J; Hennenberg, M; Neef, M; Sauerbruch, T; Schepke, M; Shiozawa, T; Trebicka, J, 2005) |
| "We studied, in rats with secondary biliary cirrhosis and sham-operated rats, the effect of 0." | 1.33 | Vascular, hemodynamic and renal effects of low-dose losartan in rats with secondary biliary cirrhosis. ( Heller, J; Hennenberg, M; Neef, M; Sauerbruch, T; Schepke, M; Shiozawa, T; Trebicka, J, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jazaeri, F | 1 |
| Afsharmoghaddam, R | 1 |
| Abdollahi, A | 1 |
| Ghamami, G | 1 |
| Dehpour, AR | 1 |
| Heller, J | 1 |
| Trebicka, J | 1 |
| Shiozawa, T | 1 |
| Schepke, M | 1 |
| Neef, M | 1 |
| Hennenberg, M | 1 |
| Sauerbruch, T | 1 |
2 other studies available for losartan and Liver Cirrhosis, Biliary
| Article | Year |
|---|---|
Evaluation of Chronic Losartan Treatment Effect on Cardiac Chronotropic Dysfunction in Biliary Cirrhotic Rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Heart Atria; Heart Rate; Ligation; Liver Cirrhosis | 2018 |
Vascular, hemodynamic and renal effects of low-dose losartan in rats with secondary biliary cirrhosis.
Topics: Adrenergic alpha-Agonists; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Dose-Response Re | 2005 |